FUSN Company Profile and Key Details
Fusion Pharmaceuticals Inc.
FUSN Stock Price Chart
Stock Price Today
Fusion Pharmaceuticals Inc. (FUSN) stock surged +0.14%, trading at $21.55 on NASDAQ, up from the previous close of $21.52. The stock opened at $21.55, fluctuating between $21.48 and $21.58 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
Company Information
| Employees | 101 |
| Beta | -0.69 |
| Sales or Revenue | $2.07M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) stock price is $21.55 in the last trading session. During the trading session, FUSN stock reached the peak price of $21.58 while $21.48 was the lowest point it dropped to. The percentage change in FUSN stock occurred in the recent session was 0.14% while the dollar amount for the price change in FUSN stock was $0.03.
The NASDAQ listed FUSN is part of Biotechnology industry that operates in the broader Healthcare sector. Fusion Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Cara Ferreira Ph.D.
Chief of Staff
Ms. Amanda Cray
Senior Director of Investor Relations & Corporation Communications
Mr. Eric S. Hoffman Ph.D.
Senior Vice President of Bus. Devel.
Dr. John F. Valliant Ph.D.
Founder, Chief Executive Officer & Director
Dr. Victor G. Paulus Ph.D.
Senior Vice President of Regulatory Affairs
Ms. Maria D. Stahl
Chief Legal Officer
Mr. Mohit Rawat
Pres & Chief Bus. Officer
Mr. John J. Crowley CPA
Chief Financial Officer
Dr. Eric Burak Ph.D.
Chief Technology Officer
Dr. Christopher Paul Leamon Ph.D.
Chief Scientific Officer
Dr. Joanne Schindler
Executive Vice President of Medical Director & Clinical Devel.
FUSN's closing price is 832.9% higher than its 52-week low of $2.31 where as its distance from 52-week high of $21.60 is -0.23%.
Number of FUSN employees currently stands at 101.
Official Website of FUSN is: https://fusionpharma.com
FUSN could be contacted at phone 289 799 0891 and can also be accessed through its website. FUSN operates from 270 Longwood Road South, Hamilton, ON L8P 0A6, Canada.
FUSN stock volume for the day was 6.08M shares. The average number of FUSN shares traded daily for last 3 months was 1.97M.
The market value of FUSN currently stands at $1.83B with its latest stock price at $21.55 and 85.06M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com